Adrenal
|
August 28, 2024

Endogenous vs. Exogenous Causes of Cushing's Disease: What You Need to Know

Medically Reviewed by
Updated On
December 12, 2024

Cushing's disease is a specific form of Cushing's syndrome caused by a pituitary tumor that overproduces ACTH, causing excessive cortisol levels. Chronically elevated cortisol levels can have widespread adverse health effects; unfortunately, as a rare disease, it can be missed by clinicians.Β 

Common symptoms often include central obesity, skin changes, muscle weakness, hypertension, and mood disturbances, which can be mistaken for other conditions such as diabetes or cardiovascular disease.Β 

Accurate diagnosis is essential to avoid the severe health risks associated with prolonged high cortisol exposure. With appropriate treatment, regular monitoring, and the implementation of healthy lifestyle measures, patients can enjoy sustained recovery and quality of life.

This article examines the differences between exogenous and endogenous Cushing's syndrome to help readers better understand the causes of this condition.

[signup]

What is Cushing's Disease?

Cushing's disease is the second most common cause of Cushing's syndrome. Cushing's disease is an endocrine disorder characterized by the overproduction of adrenocorticotropic hormone (ACTH), typically due to a benign pituitary tumor, often a small pituitary microadenoma (less than 10 mm in size).Β 

This excess ACTH disrupts the normal circadian rhythm of cortisol production, leading to excessive cortisol output from the adrenal cortex. The resulting glucocorticoid and mineralocorticoid effects can cause serious complications often overlooked in the early stages.

As the most common form of endogenous Cushing's syndrome, Cushing's disease often goes undiagnosed for 3 to 6 years, primarily diagnosed in women and adults between 30 and 40. With a mortality rate of 10-11%, untreated Cushing's disease significantly increases the risk of cardiovascular complications, infections, and mental health issues.

Managing Cushing's disease requires a multidisciplinary approach involving surgery, medication, and continuous monitoring to address its complex symptoms.

Cushing's Disease vs. Cushing's Syndrome

Cushing's disease and Cushing's syndrome are conditions characterized by excess cortisol. Cushing's syndrome is the broad term for hypercortisolism, while Cushing's disease is a subtype of this.Β 

It explains that Cushing's Syndrome is characterized by high cortisol levels in the body, which can have multiple underlying causes such as adrenal tumors or corticosteroid use.

Cushing's syndrome results from prolonged exposure to elevated cortisol levels, most often due to iatrogenic (caused by a treatment or medication) corticosteroid use or certain herbal preparations.Β 

In contrast, Cushing's disease refers specifically to the ACTH-dependent cortisol excess caused by a pituitary adenoma, accounting for 80% of endogenous Cushing syndrome cases.Β 

History of Cushing's Disease

Cushing's disease is a subtype of Cushing's syndrome.Β 

Cushing's disease was first identified in 1932 by Harvey W. Cushing, who noted a condition caused by high cortisol levels, manifesting in symptoms including muscular weakness, obesity, abdominal striae, diabetes, and arterial hypertension. He believed this condition originated in the pituitary gland, now known as Cushing's disease.Β 

Then, in the early 1950s, glucocorticoids became commonly used to treat rheumatoid arthritis. This led to the emergence of iatrogenic, or medication-caused, Cushing's syndrome.Β 

Now, with the widespread use of glucocorticoids, exogenous Cushing's syndrome is more common than Cushing's disease.

Symptoms of Cushing's Disease

While the variability and subtlety of symptoms can make diagnosis challenging, Cushing's disease has several hallmark symptoms.Β 

Weight Gain and Fat Distribution

Excess cortisol leads to central obesity, characterized by fat accumulation in the abdomen, face ("moon face"), and upper back ("buffalo hump"). This is due to cortisol's role in fat storage, particularly in these areas.

Skin Changes

Excess cortisol causes thinning skin, slow wound healing, and the appearance of purple stretch marks (striae) on areas like the abdomen and thighs due to the disruption of collagen production and skin structure. Acne and changes in hair growth patterns can also be seen.Β 

Muscle Weakness and Fatigue

Muscle wasting and weakness, particularly in the limbs, occur as cortisol disrupts the balance between muscle protein synthesis and breakdown, leading to a noticeable contrast between a large belly and thin arms and legs.

Mood Changes

Cushing's disease often results in mood disturbances such as depression, anxiety, and cognitive impairment, as elevated cortisol negatively impacts brain regions like the hippocampus.

High Blood Pressure

Hypertension in Cushing's disease is caused by cortisol's effects on fluid retention, vascular responsiveness, and inhibition of nitric oxide, all contributing to elevated blood pressure.

Bone Health Issues

Osteoporosis is a common consequence of hypercortisolism. Cortisol increases bone resorption, decreases bone formation, and disrupts calcium balance, leading to fragile bones and back pain from vertebral fractures.

Reproductive and Sexual Health Symptoms

Women with Cushing's disease may experience menstrual irregularities due to cortisol's interference with the hypothalamic-pituitary-gonadal axis, while men may suffer from decreased libido and erectile dysfunction.

Other Important Symptoms

Patients might also experience increased thirst and urination, headaches, visual disturbances, and decreased immunity, all linked to cortisol's widespread effects on various body systems.

These symptoms may be mistaken for other conditions, such as diabetes or cardiovascular disease, which can miss the root cause of the individual's illness.

It is also important to note that headaches and visual disturbances are rare findings in Cushing's disease, so other causes, such as intracranial hypertension, should also be ruled out.

Why Cortisol Levels Matter

Cortisol plays a role in regulating metabolism, immune response, and stress management under normal conditions. It is also essential in fetal development.Β 

However, in Cushing's disease, chronically elevated cortisol levels disrupt these functions, leading to a range of symptoms.

Excess cortisol primarily exerts glucocorticoid effects, causing muscle weakness, osteoporosis, hyperglycemia, insulin resistance, weight gain, and an increased risk of cardiovascular disease. It also has mineralocorticoid effects, contributing to hypertension, sodium retention, and potassium depletion.

Prolonged exposure to high cortisol levels in Cushing's disease is also linked to neuropsychiatric and cognitive issues such as emotional instability, depression, anxiety, impulsivity, and cognitive deficits.

Endogenous Causes of Cushing's Disease

Endogenous Cushing's syndrome is always associated with excessive cortisol production from the adrenal cortex. It can be ACTH-dependent or ACTH-independent.

Pituitary Adenomas

Pituitary adenomas, primarily pituitary microadenomas (tumors < 10 mm), are the most common endogenous cause of Cushing's disease. They are responsible for 80% of all diagnoses of Cushing's syndrome, making them the second most common cause of this syndrome.

These pituitary adenomas secrete ACTH, leading to excessive cortisol output from the adrenal cortex, which in turn causes the symptoms associated with Cushing's disease.Β 

While this condition is rare overall, early diagnosis and treatment are essential to improve prognosis and reduce the risk of complications from hypercortisolism, which increases the risk of many health complications.

Ectopic ACTH Syndrome

Ectopic ACTH syndrome is a rare form of Cushing's syndrome caused by non-pituitary neuroendocrine tumors producing ACTH, often lung and GI tract cancers. This accounts for approximately 10% of diagnoses of ACTH-dependent Cushing's syndrome.

These neuroendocrine tumors produce adrenocorticotropic hormone (ACTH) or corticotropin-releasing hormone (CRH), which leads to hypercortisolemia and the typical Cushing's manifestation.

Unfortunately, these tumors can be challenging to identify as well as aggressive, leading to rapid progression of symptoms, complications including infections and excessive blood clots, and poor prognosis.Β 

Adrenal Adenomas or Hyperplasia

Adrenal adenomas are benign, encapsulated cortical tumors, while adrenal hyperplasia involves diffuse or nodular enlargement of the gland. Either of these conditions can cause hypercortisolism by directly increasing cortisol output.Β 

In these settings, the adrenal gland is directly responsible for hypercortisolism; therefore, this is considered an ACTH-independent cause of Cushing's syndrome.Β 

In contrast, Cushing's disease is ACTH-dependent due to a pituitary tumor over-secreting ACTH, which then overstimulates adrenal production of cortisol.

Adrenal adenomas are typically unilateral (affecting one adrenal gland), while hyperplasia can be bilateral (affecting both glands).

The condition can be identified through imaging, where unilateral masses in the adrenal glands indicate adenomas. Surgical removal is often curative.

Some genetic mutations in cortisol-producing adrenal adenomas and unilateral hyperplasia have been linked to more severe Cushing's syndrome, suggesting that genetic testing should also be considered.

Exogenous Causes of Cushing's Syndrome

Exogenous causes of Cushing's syndrome refer to the condition resulting from external sources:

Long-Term Use of Corticosteroid Medications

Glucocorticoids are widely used to treat autoimmune diseases, hematological disorders, and inflammatory conditions like rheumatoid arthritis and psoriasis.Β 

While short-term use rarely causes withdrawal issues, prolonged use, especially in children under 5, can lead to adrenal lesions, hyperplasia, and significant challenges.Β 

Extended use overstimulates body-wide glucocorticoid receptors and suppresses the HPA axis, reducing CRH and ACTH secretion.

These effects increase the risk of complications such as hypertension, dyslipidemia, cardiovascular disease, and infections, contributing to the morbidity and mortality associated with Cushing's syndrome.

Diagnosing Cushing's Disease: Endogenous vs. Exogenous

The symptoms of exogenous and endogenous Cushing's syndrome, including Cushing's disease, can mirror each other. If Cushing's syndrome is suspected, an appropriate diagnostic workup is necessary to determine the cause of excess cortisol.

Diagnostic Tests

  • 24-Hour Urinary Free Cortisol (UFC) Test: The Endocrine Society recommends this key screening tool to assess elevated daily cortisol production, a hallmark of Cushing's syndrome.
  • Dexamethasone Suppression Test: also recommended by the Endocrine Society, this test involves taking dexamethasone at night and measuring cortisol the following morning. Elevated cortisol indicates excessive production and loss of negative feedback.
  • Blood and Saliva Tests: Measuring cortisol levels at different times of the day
  • Late-Night Salivary Cortisol: a noninvasive test measuring cortisol at bedtime to detect circadian rhythm loss; requires two measurements.
  • Midnight Serum Cortisol: Measures cortisol at its lowest point (midnight) but may need inpatient admission to avoid stress-induced false positives.

Imaging Studies

  • MRI and CT Scans: MRI is preferred for detecting pituitary microadenomas, while CT is typically used for identifying adrenal tumors or hyperplasia.
  • PET Scans: PET scans are used as a complementary tool when MRI or CT results are inconclusive. They help identify ectopic ACTH sources or clarify adrenal findings.

Medical History and Medication Review

Obtaining a thorough drug history before testing for Cushing's syndrome to exclude exogenous glucocorticoid exposure, which can lead to iatrogenic Cushing's syndrome, is necessary.Β 

Clinicians should carefully review current or recent use of medications, including oral, rectal, inhaled, topical, or injected glucocorticoids, as well as herbal medicines and "tonics" that may contain glucocorticoids.Β 

This includes assessing the use of certain medications that can cause Cushing's syndrome at high doses, like megestrol acetate (a synthetic progesterone with glucocorticoid activity), to cause Cushing's syndrome at high doses.

Treatment Options Based on the Cause

Treatment options for Cushing's syndrome depend on the underlying cause.

Treatment for Endogenous Cushing's Syndrome

The following treatments are focused on treating endogenous causes:

Surgery

Surgical removal of the primary lesion is the preferred initial treatment for Cushing's syndrome. This includes transsphenoidal selective adenomectomy (TSS) for pituitary tumors, adrenalectomy for adrenal lesions, and resection of ectopic ACTH-secreting tumors.Β 

Bilateral adrenalectomy is recommended for patients with severe, life-threatening ACTH-dependent disease unresponsive to medical therapy or occult/metastatic ectopic ACTH secretion (EAS). It is also a second-line option if other treatments fail.

Radiation Therapy

Radiation therapy (RT) or radiosurgery is recommended for patients with Cushing's disease who have failed transsphenoidal surgery or have recurrent disease and when mass effects or invasion from corticotroph adenomas are a concern.

Medications

Pharmaceutical drugs are prescribed on an individualized basis.

  • Steroidogenesis Inhibitors: Ketoconazole, metyrapone, and mitotane are recommended for hypercortisolism in patients unable to undergo or who failed surgery or while awaiting radiation.
  • Pituitary-Directed Treatments: Cabergoline and pasireotide are suggested for non-surgical candidates or those with persistent disease.
  • Glucocorticoid Antagonists: Mifepristone is recommended for patients with diabetes or persistent disease post-surgery.
  • Combination therapy may improve efficacy, especially in severe cases.

Treatment for Exogenous Cushing's Syndrome

The following treatments focus on treating the exogenous causes:

Gradual Reduction of Corticosteroids

While discontinuation after a short course (weeks to a few months) usually doesn't pose significant issues, withdrawal after prolonged use (months to years) is more complex and requires a gradual taper. Alternate-day dosing and hydrocortisone replacement may be considered.Β 

Alternative Treatments

Glucocorticoids should be discontinued only when the underlying disease is in long-term remission. If the disease is still active, alternative treatments should be considered.

Ongoing monitoring for persistent issues like hypertension, diabetes, and cardiovascular problems is necessary even after hypercortisolism is controlled.

Monitoring and Support

Appropriate long-term care and regular follow-ups are necessary to ensure cortisol levels return to normal.

Long-Term Outlook and Management

The long-term outlook and management of Cushing's syndrome focus on controlling the cause, monitoring for complications, and making lifestyle adjustments to improve overall health.

Recovery and Monitoring

  • Ongoing Management of Comorbidities: Patients need lifelong management of Cushing-associated comorbidities, such as cardiovascular risk factors, osteoporosis, and psychiatric symptoms, as these issues may persist or recur.
  • Recurrence Monitoring: Regular testing for Cushing disease recurrence is generally recommended throughout the patient's life.
  • Medical Monitoring: Ongoing medical support is essential for early detection and management of complications like hypertension, diabetes, osteoporosis, and psychological issues.
  • Regular Follow-Ups: Ensure prompt treatment of emerging problems, supporting long-term health and quality of life.

Lifestyle Adjustments

These are foundational for recovery. Focus on a healthy diet, regular exercise, good sleep, and stress management to support HPA axis function and overall well-being.

  • Balanced diet: Helps manage weight, blood sugar, and bone health.
  • Regular exercise: Improves cardiovascular health, muscle strength, and mood.
  • Stress management: Prevents cortisol fluctuations, aiding recovery.

[signup]

Key Takeaways

  • Cushing's disease is a specific type of Cushing's syndrome caused by a pituitary tumor that overproduces ACTH, leading to excessive cortisol. It accounts for 80% of endogenous Cushing's syndrome cases, while the broader term includes both endogenous and exogenous causes.
  • Accurate diagnosis is critical due to the harmful effects of high cortisol, which leads to central obesity, skin changes, muscle weakness, hypertension, and mood disturbances.Β 
  • Treatment typically involves surgical removal of the pituitary tumor, with radiation or medication, if surgery is not effective. Exogenous Cushing's syndrome, often due to prolonged corticosteroid use, requires careful tapering of the drug. Long-term care includes maintaining a healthy diet and lifestyle.
  • Patients recovering from Cushing's disease require lifelong monitoring to watch for recurrence and manage comorbidities like cardiovascular issues, osteoporosis, and psychiatric symptoms. Regular follow-ups, a healthy lifestyle, and stress management are vital for long-term recovery and quality of life.
  • Recovery is possible with proper treatment and support, offering a path to a healthier, more fulfilling life. Resources like your doctor and the Cushing's Support and Research Foundation can aid your journey.

Cushing's disease is a specific form of Cushing's syndrome caused by a pituitary tumor that overproduces ACTH, leading to increased cortisol levels. Chronically elevated cortisol levels can have widespread health effects; unfortunately, as a rare disease, it can be missed by clinicians.Β 

Common symptoms often include central obesity, skin changes, muscle weakness, hypertension, and mood disturbances, which can be mistaken for other conditions such as diabetes or cardiovascular disease.Β 

Accurate diagnosis is essential to manage the health risks associated with prolonged high cortisol exposure. With appropriate treatment, regular monitoring, and the implementation of healthy lifestyle measures, patients can enjoy improved quality of life.

This article examines the differences between exogenous and endogenous Cushing's syndrome to help readers better understand the causes of this condition.

[signup]

What is Cushing's Disease?

Cushing's disease is the second most common cause of Cushing's syndrome. Cushing's disease is an endocrine disorder characterized by the overproduction of adrenocorticotropic hormone (ACTH), typically due to a benign pituitary tumor, often a small pituitary microadenoma (less than 10 mm in size).Β 

This excess ACTH disrupts the normal circadian rhythm of cortisol production, leading to increased cortisol output from the adrenal cortex. The resulting glucocorticoid and mineralocorticoid effects can cause complications often overlooked in the early stages.

As the most common form of endogenous Cushing's syndrome, Cushing's disease often goes undiagnosed for 3 to 6 years, primarily diagnosed in women and adults between 30 and 40. With a mortality rate of 10-11%, untreated Cushing's disease significantly increases the risk of cardiovascular complications, infections, and mental health issues.

Managing Cushing's disease requires a multidisciplinary approach involving surgery, medication, and continuous monitoring to address its complex symptoms.

Cushing's Disease vs. Cushing's Syndrome

Cushing's disease and Cushing's syndrome are conditions characterized by excess cortisol. Cushing's syndrome is the broad term for hypercortisolism, while Cushing's disease is a subtype of this.Β 

It explains that Cushing's Syndrome is characterized by high cortisol levels in the body, which can have multiple underlying causes such as adrenal tumors or corticosteroid use.

Cushing's syndrome results from prolonged exposure to elevated cortisol levels, most often due to iatrogenic (caused by a treatment or medication) corticosteroid use or certain herbal preparations.Β 

In contrast, Cushing's disease refers specifically to the ACTH-dependent cortisol excess caused by a pituitary adenoma, accounting for 80% of endogenous Cushing syndrome cases.Β 

History of Cushing's Disease

Cushing's disease is a subtype of Cushing's syndrome.Β 

Cushing's disease was first identified in 1932 by Harvey W. Cushing, who noted a condition caused by high cortisol levels, manifesting in symptoms including muscular weakness, obesity, abdominal striae, diabetes, and arterial hypertension. He believed this condition originated in the pituitary gland, now known as Cushing's disease.Β 

Then, in the early 1950s, glucocorticoids became commonly used to treat rheumatoid arthritis. This led to the emergence of iatrogenic, or medication-caused, Cushing's syndrome.Β 

Now, with the widespread use of glucocorticoids, exogenous Cushing's syndrome is more common than Cushing's disease.

Symptoms of Cushing's Disease

While the variability and subtlety of symptoms can make diagnosis challenging, Cushing's disease has several hallmark symptoms.Β 

Weight Gain and Fat Distribution

Excess cortisol may lead to central obesity, characterized by fat accumulation in the abdomen, face ("moon face"), and upper back ("buffalo hump"). This is due to cortisol's role in fat storage, particularly in these areas.

Skin Changes

Excess cortisol may cause thinning skin, slow wound healing, and the appearance of purple stretch marks (striae) on areas like the abdomen and thighs due to the disruption of collagen production and skin structure. Acne and changes in hair growth patterns can also be seen.Β 

Muscle Weakness and Fatigue

Muscle wasting and weakness, particularly in the limbs, may occur as cortisol disrupts the balance between muscle protein synthesis and breakdown, leading to a noticeable contrast between a large belly and thin arms and legs.

Mood Changes

Cushing's disease often results in mood disturbances such as depression, anxiety, and cognitive impairment, as elevated cortisol may impact brain regions like the hippocampus.

High Blood Pressure

Hypertension in Cushing's disease may be influenced by cortisol's effects on fluid retention, vascular responsiveness, and inhibition of nitric oxide, all contributing to elevated blood pressure.

Bone Health Issues

Osteoporosis is a common consequence of hypercortisolism. Cortisol may increase bone resorption, decrease bone formation, and disrupt calcium balance, leading to fragile bones and back pain from vertebral fractures.

Reproductive and Sexual Health Symptoms

Women with Cushing's disease may experience menstrual irregularities due to cortisol's interference with the hypothalamic-pituitary-gonadal axis, while men may suffer from decreased libido and erectile dysfunction.

Other Important Symptoms

Patients might also experience increased thirst and urination, headaches, visual disturbances, and decreased immunity, all linked to cortisol's widespread effects on various body systems.

These symptoms may be mistaken for other conditions, such as diabetes or cardiovascular disease, which can miss the root cause of the individual's illness.

It is also important to note that headaches and visual disturbances are rare findings in Cushing's disease, so other causes, such as intracranial hypertension, should also be ruled out.

Why Cortisol Levels Matter

Cortisol plays a role in regulating metabolism, immune response, and stress management under normal conditions. It is also essential in fetal development.Β 

However, in Cushing's disease, chronically elevated cortisol levels may disrupt these functions, leading to a range of symptoms.

Excess cortisol primarily exerts glucocorticoid effects, which may cause muscle weakness, osteoporosis, hyperglycemia, insulin resistance, weight gain, and an increased risk of cardiovascular disease. It also has mineralocorticoid effects, contributing to hypertension, sodium retention, and potassium depletion.

Prolonged exposure to high cortisol levels in Cushing's disease is also linked to neuropsychiatric and cognitive issues such as emotional instability, depression, anxiety, impulsivity, and cognitive deficits.

Endogenous Causes of Cushing's Disease

Endogenous Cushing's syndrome is always associated with excessive cortisol production from the adrenal cortex. It can be ACTH-dependent or ACTH-independent.

Pituitary Adenomas

Pituitary adenomas, primarily pituitary microadenomas (tumors < 10 mm), are the most common endogenous cause of Cushing's disease. They are responsible for 80% of all diagnoses of Cushing's syndrome, making them the second most common cause of this syndrome.

These pituitary adenomas secrete ACTH, leading to excessive cortisol output from the adrenal cortex, which in turn causes the symptoms associated with Cushing's disease.Β 

While this condition is rare overall, early diagnosis and treatment are essential to improve prognosis and reduce the risk of complications from hypercortisolism, which increases the risk of many health complications.

Ectopic ACTH Syndrome

Ectopic ACTH syndrome is a rare form of Cushing's syndrome caused by non-pituitary neuroendocrine tumors producing ACTH, often lung and GI tract cancers. This accounts for approximately 10% of diagnoses of ACTH-dependent Cushing's syndrome.

These neuroendocrine tumors produce adrenocorticotropic hormone (ACTH) or corticotropin-releasing hormone (CRH), which leads to hypercortisolemia and the typical Cushing's manifestation.

Unfortunately, these tumors can be challenging to identify as well as aggressive, leading to rapid progression of symptoms, complications including infections and excessive blood clots, and poor prognosis.Β 

Adrenal Adenomas or Hyperplasia

Adrenal adenomas are benign, encapsulated cortical tumors, while adrenal hyperplasia involves diffuse or nodular enlargement of the gland. Either of these conditions can cause hypercortisolism by directly increasing cortisol output.Β 

In these settings, the adrenal gland is directly responsible for hypercortisolism; therefore, this is considered an ACTH-independent cause of Cushing's syndrome.Β 

In contrast, Cushing's disease is ACTH-dependent due to a pituitary tumor over-secreting ACTH, which then overstimulates adrenal production of cortisol.

Adrenal adenomas are typically unilateral (affecting one adrenal gland), while hyperplasia can be bilateral (affecting both glands).

The condition can be identified through imaging, where unilateral masses in the adrenal glands indicate adenomas. Surgical removal is often curative.

Some genetic mutations in cortisol-producing adrenal adenomas and unilateral hyperplasia have been linked to more severe Cushing's syndrome, suggesting that genetic testing should also be considered.

Exogenous Causes of Cushing's Syndrome

Exogenous causes of Cushing's syndrome refer to the condition resulting from external sources:

Long-Term Use of Corticosteroid Medications

Glucocorticoids are widely used to treat autoimmune diseases, hematological disorders, and inflammatory conditions like rheumatoid arthritis and psoriasis.Β 

While short-term use rarely causes withdrawal issues, prolonged use, especially in children under 5, can lead to adrenal lesions, hyperplasia, and significant challenges.Β 

Extended use may overstimulate body-wide glucocorticoid receptors and suppress the HPA axis, reducing CRH and ACTH secretion.

These effects may increase the risk of complications such as hypertension, dyslipidemia, cardiovascular disease, and infections, contributing to the morbidity and mortality associated with Cushing's syndrome.

Diagnosing Cushing's Disease: Endogenous vs. Exogenous

The symptoms of exogenous and endogenous Cushing's syndrome, including Cushing's disease, can mirror each other. If Cushing's syndrome is suspected, an appropriate diagnostic workup is necessary to determine the cause of excess cortisol.

Diagnostic Tests

  • 24-Hour Urinary Free Cortisol (UFC) Test: The Endocrine Society recommends this key screening tool to assess elevated daily cortisol production, a hallmark of Cushing's syndrome.
  • Dexamethasone Suppression Test: also recommended by the Endocrine Society, this test involves taking dexamethasone at night and measuring cortisol the following morning. Elevated cortisol indicates excessive production and loss of negative feedback.
  • Blood and Saliva Tests: Measuring cortisol levels at different times of the day
  • Late-Night Salivary Cortisol: a noninvasive test measuring cortisol at bedtime to detect circadian rhythm loss; requires two measurements.
  • Midnight Serum Cortisol: Measures cortisol at its lowest point (midnight) but may need inpatient admission to avoid stress-induced false positives.

Imaging Studies

  • MRI and CT Scans: MRI is preferred for detecting pituitary microadenomas, while CT is typically used for identifying adrenal tumors or hyperplasia.
  • PET Scans: PET scans are used as a complementary tool when MRI or CT results are inconclusive. They help identify ectopic ACTH sources or clarify adrenal findings.

Medical History and Medication Review

Obtaining a thorough drug history before testing for Cushing's syndrome to exclude exogenous glucocorticoid exposure, which can lead to iatrogenic Cushing's syndrome, is necessary.Β 

Clinicians should carefully review current or recent use of medications, including oral, rectal, inhaled, topical, or injected glucocorticoids, as well as herbal medicines and "tonics" that may contain glucocorticoids.Β 

This includes assessing the use of certain medications that can cause Cushing's syndrome at high doses, like megestrol acetate (a synthetic progesterone with glucocorticoid activity), to cause Cushing's syndrome at high doses.

Treatment Options Based on the Cause

Treatment options for Cushing's syndrome depend on the underlying cause.

Treatment for Endogenous Cushing's Syndrome

The following treatments are focused on treating endogenous causes:

Surgery

Surgical removal of the primary lesion is the preferred initial treatment for Cushing's syndrome. This includes transsphenoidal selective adenomectomy (TSS) for pituitary tumors, adrenalectomy for adrenal lesions, and resection of ectopic ACTH-secreting tumors.Β 

Bilateral adrenalectomy is recommended for patients with severe, life-threatening ACTH-dependent disease unresponsive to medical therapy or occult/metastatic ectopic ACTH secretion (EAS). It is also a second-line option if other treatments fail.

Radiation Therapy

Radiation therapy (RT) or radiosurgery is recommended for patients with Cushing's disease who have failed transsphenoidal surgery or have recurrent disease and when mass effects or invasion from corticotroph adenomas are a concern.

Medications

Pharmaceutical drugs are prescribed on an individualized basis.

  • Steroidogenesis Inhibitors: Ketoconazole, metyrapone, and mitotane are recommended for hypercortisolism in patients unable to undergo or who failed surgery or while awaiting radiation.
  • Pituitary-Directed Treatments: Cabergoline and pasireotide are suggested for non-surgical candidates or those with persistent disease.
  • Glucocorticoid Antagonists: Mifepristone is recommended for patients with diabetes or persistent disease post-surgery.
  • Combination therapy may improve efficacy, especially in severe cases.

Treatment for Exogenous Cushing's Syndrome

The following treatments focus on treating the exogenous causes:

Gradual Reduction of Corticosteroids

While discontinuation after a short course (weeks to a few months) usually doesn't pose significant issues, withdrawal after prolonged use (months to years) is more complex and requires a gradual taper. Alternate-day dosing and hydrocortisone replacement may be considered.Β 

Alternative Treatments

Glucocorticoids should be discontinued only when the underlying disease is in long-term remission. If the disease is still active, alternative treatments should be considered.

Ongoing monitoring for persistent issues like hypertension, diabetes, and cardiovascular problems is necessary even after hypercortisolism is controlled.

Monitoring and Support

Appropriate long-term care and regular follow-ups are necessary to ensure cortisol levels return to normal.

Long-Term Outlook and Management

The long-term outlook and management of Cushing's syndrome focus on controlling the cause, monitoring for complications, and making lifestyle adjustments to improve overall health.

Recovery and Monitoring

  • Ongoing Management of Comorbidities: Patients need lifelong management of Cushing-associated comorbidities, such as cardiovascular risk factors, osteoporosis, and psychiatric symptoms, as these issues may persist or recur.
  • Recurrence Monitoring: Regular testing for Cushing disease recurrence is generally recommended throughout the patient's life.
  • Medical Monitoring: Ongoing medical support is essential for early detection and management of complications like hypertension, diabetes, osteoporosis, and psychological issues.
  • Regular Follow-Ups: Ensure prompt treatment of emerging problems, supporting long-term health and quality of life.

Lifestyle Adjustments

These are foundational for recovery. Focus on a healthy diet, regular exercise, good sleep, and stress management to support HPA axis function and overall well-being.

  • Balanced diet: Helps manage weight, blood sugar, and bone health.
  • Regular exercise: Improves cardiovascular health, muscle strength, and mood.
  • Stress management: May help prevent cortisol fluctuations, aiding recovery.

[signup]

Key Takeaways

  • Cushing's disease is a specific type of Cushing's syndrome caused by a pituitary tumor that overproduces ACTH, leading to increased cortisol. It accounts for 80% of endogenous Cushing's syndrome cases, while the broader term includes both endogenous and exogenous causes.
  • Accurate diagnosis is critical due to the potential effects of high cortisol, which may lead to central obesity, skin changes, muscle weakness, hypertension, and mood disturbances.Β 
  • Treatment typically involves surgical removal of the pituitary tumor, with radiation or medication, if surgery is not effective. Exogenous Cushing's syndrome, often due to prolonged corticosteroid use, requires careful tapering of the drug. Long-term care includes maintaining a healthy diet and lifestyle.
  • Patients recovering from Cushing's disease require lifelong monitoring to watch for recurrence and manage comorbidities like cardiovascular issues, osteoporosis, and psychiatric symptoms. Regular follow-ups, a healthy lifestyle, and stress management are vital for long-term recovery and quality of life.
  • Recovery is possible with proper treatment and support, offering a path to a healthier, more fulfilling life. Resources like your doctor and the Cushing's Support and Research Foundation can aid your journey.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. The Surprising Health Benefits of an Extra Hour of Sleep for College Students. (2024, February 12). Rupa Health. https://www.rupahealth.com/post/the-surprising-health-benefits-of-an-extra-hour-of-sleep-for-college-students

Arroyo, R., Belmontes, P., Marlene, Mendoza, R., Gonzalez, B. E., Bonilla, N. C., Aran, & Santiago, G. G. (2023). Drug induced iatrogenic Cushing's syndrome. International Journal of Research in Medical Sciences, 12(1), 303–308. https://doi.org/10.18203/2320-6012.ijrms20234026

Barbot, M., Ceccato, F., & Scaroni, C. (2019). The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome. Frontiers in endocrinology, 10, 321. https://doi.org/10.3389/fendo.2019.00321

Bryant, A. Rupa Health. Emerging Therapies in the Management of Endocrine Hypertension: A Look into the Future. Published March 7, 2024. Accessed August 23, 2024. https://www.rupahealth.com/post/emerging-therapies-in-the-management-of-endocrine-hypertension-a-look-into-the-futureΒ 

Buliman, A., Tataranu, L. G., Paun, D. L., Mirica, A., & Dumitrache, C. (2016). Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. Journal of medicine and life, 9(1), 12–18.

Castinetti, F., Morange, I., Conte-Devolx, B. et al. Cushing's disease. Orphanet J Rare Dis 7, 41 (2012). https://doi.org/10.1186/1750-1172-7-41

Chaudhry HS, Singh G. Cushing Syndrome. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470218/

Chen, Y., Li, Y., Chen, X., & Sun, Q. (2013). Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease. Chinese Medical Journal, 126(16), 3156–3160. https://doi.org/10.3760/cma.j.issn.0366-6999.20130944

Chourpiliadis C, Aeddula NR. Physiology, Glucocorticoids. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560897/Β 

Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesityΒ 

Cizza, G., & Chrousos, G. P. (1997). Adrenocorticotrophic hormone-dependent Cushing's syndrome. Cancer treatment and research, 89, 25–40. https://doi.org/10.1007/978-1-4615-6355-6_2

Cloyd, J. A Root Cause Medicine Protocol For Patients With Osteoporosis: Testing, Therapeutic Diet, and Supportive Supplements. (2023, September 6). Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-osteoporosis-testing-therapeutic-diet-and-supportive-supplements

Cloyd, J. (2022, August 17). An Integrative Medicine Approach to Rheumatology. Rupa Health. https://www.rupahealth.com/post/6-common-types-of-arthritisΒ 

Cloyd, J. (2024, June 7). Cortisol and Anxiety: Understanding the Connection. Rupa Health. https://www.rupahealth.com/post/cortisol-and-anxietyΒ 

Cloyd, J. Cortisol and Weight Gain: Understanding the Connection. (2024, April 15). Rupa Health. https://www.rupahealth.com/post/cortisol-and-weight-gain-understanding-the-connection

Cloyd, J. How to Relieve Low Back Pain Naturally: A Functional Medicine Approach. (2023, October 10). Rupa Health. https://www.rupahealth.com/post/how-to-relieve-low-back-pain-naturally-a-functional-medicine-approach

Cloyd J. An Integrative Medicine Approach to Rheumatology. Rupa Health. Published August 17, 2022. https://www.rupahealth.com/post/6-common-types-of-arthritisΒ 

Cortisol. Rupa Health. https://www.rupahealth.com/biomarkers/cortisolΒ 

Cox, A. 5 Science Backed Health Benefits of Collagen. (2022, November 3). Rupa Health. https://www.rupahealth.com/post/5-science-backed-health-benefits-of-collagenΒ 

CSRF - Cushing's Support & Research Foundation - Cushing's Syndrome Resources. CSRF - Cushing's Support & Research Foundation. https://csrf.net/Β 

DePorto, T. (2023, February 1). The Gut's Role in The Development and Treatment of Psoriasis: A Integrative Medicine Approach. Rupa Health. https://www.rupahealth.com/post/the-guts-role-in-the-development-and-treatment-of-psoriasis-a-integrative-medicine-approachΒ 

DePorto T. Worried About Heart Disease? Ask Your Provider for These 6 Specialty Labs at Your Next Appointment. Rupa Health. Published December 9, 2022. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointmentΒ 

Diorio, B. (2023, January 27). Functional medicine labs that are important for longevity and cognition. Rupa Health. https://www.rupahealth.com/post/functional-medicine-labs-that-are-important-to-longevity-and-cognition

Diorio, B. (2023, March 17). How to test for hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Rupa Health. https://www.rupahealth.com/post/what-is-the-hypothalamic-pituitary-adrenal-hpa-axis

Ejaz, S., Vassilopoulou-Sellin, R., Busaidy, N. L., Hu, M. I., Waguespack, S. G., Jimenez, C., Ying, A. K., Cabanillas, M., Abbara, M., & Habra, M. A. (2011). Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer, 117(19), 4381–4389. https://doi.org/10.1002/cncr.26029

Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., Casanueva, F. F., Castinetti, F., Chanson, P., Findling, J., Gadelha, M., Geer, E. B., Giustina, A., Grossman, A., Gurnell, M., Ho, K., … Biller, B. M. K. (2021). Consensus on diagnosis and management of Cushing's disease: a guideline update. The lancet. Diabetes & endocrinology, 9(12), 847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Halimova, Z., & Irgasheva, O. B. (2021). Turakulov Republican Specialized Scientific and Practical Medical Center of Endocrinology of the Ministry of Health of the Republic of Uzbekistan, Tashkent, Republic of Uzbekistan. INTERNATIONAL JOURNAL of ENDOCRINOLOGY (Ukraine), 16(4), 310–315. https://doi.org/10.22141/2224-0721.16.4.2020.208483

Han, S. Y., Kim, B. H., Jang, H. R., Kim, W. J., Jeon, Y. K., Kim, S. S., & Kim, I. J. (2016). Ectopic ACTH syndrome caused by pulmonary carcinoid tumor mimicking long-standing sclerosing hemangioma. The Korean Journal of Internal Medicine, 31(4), 794–797. https://doi.org/10.3904/kjim.2014.320

Hasenmajer, V., Sbardella, E., Sciarra, F., Minnetti, M., Isidori, A. M., & Venneri, M. A. (2020). The Immune System in Cushing's Syndrome. Trends in Endocrinology & Metabolism, 31(9), 655–669. https://doi.org/10.1016/j.tem.2020.04.004

Irvine, E., Yap, Y. W., Purewal, T., & Irvine, E. (2017). A case of acute confusion: Cushing's syndrome presenting with primary hyperparathyroidism. BMJ case reports, 2017, bcr2016218694. https://doi.org/10.1136/bcr-2016-218694

Jalal, F. H., & Rajoo, S. (2021). INTRACRANIAL HYPERTENSION: A RARE BUT IMPORTANT CAUSE OF HEADACHE IN A YOUNG FEMALE WITH CUSHING'S DISEASE. Journal of the ASEAN Federation of Endocrine Societies, 37(2021), 44–44. https://doi.org/10.15605/jafes.036.s59

Kairys N, Anastasopoulou C, Schwell A. Cushing Disease. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448184/

Khakham, C. A Root Cause Medicine Approach: A Comprehensive Guide On How To Test For Low Nitric Oxide Levels. (2023, August 17). Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-approach-a-comprehensive-guide-on-how-to-test-for-low-nitric-oxide-levelsΒ 

Khakham, C. Top Labs To Run Bi-Annually On Your Depression Patients. (2023, July 28). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-depression-patients

Khakham, C. (2023, August 25). Top Labs To Run Bi-Annually On Your High Blood Pressure Patients. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-high-blood-pressure-patients

Khakham, C. Top Labs To Run Bi-Annually On Your Male Low Libido Patients. (2023, August 4). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-male-low-libido-patients

Lang, B. H. & Lo, C.-Y. (2009). Cushing's Disease and Syndrome. Springer EBooks, 379–390. https://doi.org/10.1007/978-1-84628-881-4_28

Lee, I. H., Miller, N. R., Zan, E., Tavares, F., Blitz, A. M., Sung, H., Yousem, D. M., & Boland, M. V. (2015). Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia. American Journal of Roentgenology, 205(5), W512–W518. https://doi.org/10.2214/ajr.15.14527

Magerman R. Cortisol Effects in Depression with Stress Management Tips. (2024, June 20). Rupa Health. https://www.rupahealth.com/post/cortisol-and-depressionΒ 

Mahmood E, Loughner CL, Anastasopoulou C. Adrenal Adenoma. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539906/

Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies

Menconi, M., Fareed, M., O'Neal, P., Poylin, V., Wei, W., & Hasselgren, P. O. (2007). Role of glucocorticoids in the molecular regulation of muscle wasting. Critical care medicine, 35(9 Suppl), S602–S608. https://doi.org/10.1097/01.CCM.0000279194.11328.77

Nath, A., Murthy, G.V.S., Babu, G.R. et al. Effect of prenatal exposure to maternal cortisol and psychological distress on infant development in Bengaluru, southern India: a prospective cohort study. BMC Psychiatry 17, 255 (2017). https://doi.org/10.1186/s12888-017-1424-x

Naz, M. S. G., Dovom, M. R., & Tehrani, F. R. (2020). [PDF] The Menstrual Disturbances in Endocrine Disorders: A Narrative Review | Semantic Scholar. (2019). Semanticscholar.org. https://www.semanticscholar.org/reader/25b7d5b8b6d495d6fd5b1dd39f36d78481e88b53

Nieman L. K. (2018). Recent Updates on the Diagnosis and Management of Cushing's Syndrome. Endocrinology and metabolism (Seoul, Korea), 33(2), 139–146. https://doi.org/10.3803/EnM.2018.33.2.139

Nieman, L. K., Biller, B. M., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008). The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 93(5), 1526–1540. https://doi.org/10.1210/jc.2008-0125

Nieman, L. K., Biller, B. M., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., Tabarin, A., & Endocrine Society (2015). Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 100(8), 2807–2831. https://doi.org/10.1210/jc.2015-1818

OMAE, T., KAWASAKI, T., TANAKA, K., ARAKAWA, K., EMOTO, K., MASAKI, J., & SHIBANOSUKE KATSUKI. (1971). Hyperaldosteronism due to Adrenocortical Adenoma and Adenomatous Hyperplasia. Endocrinologia Japonica, 18(1), 57–66. https://doi.org/10.1507/endocrj1954.18.57

Orbeta, R. (2022, June 6). 10 Type 2 Diabetes Risk Factors You May Not Know About. Rupa Health. https://www.rupahealth.com/post/what-causes-type-2-diabetesΒ 

Orth, D.N. (1984). The old and the new in Cushing's syndrome. The New England journal of medicine, 310 10, 649-51.

PaleΕ„-Tytko, J. E., Przybylik-Mazurek, E. M., Rzepka, E. J., Pach, D. M., Sowa-Staszczak, A. S., Gilis-Januszewska, A., & Hubalewska-Dydejczyk, A. B. (2020). Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre. PloS one, 15(11), e0242679. https://doi.org/10.1371/journal.pone.0242679

Potassium. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/potassiumΒ 

RamΓ­rez-Villaescusa, J., Ruiz-Picazo, D., Oliveira, C. L., & Morillas-AriΓ±o, C. (2020). Secondary thoracolumbar deformity and sagittal imbalance due to osteoporosis in a young man with Cushing's disease: A case report. International journal of surgery case reports, 76, 134–138. https://doi.org/10.1016/j.ijscr.2020.09.182

Sodium. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/sodiumΒ 

Stratakis C. A. (2016). Skin manifestations of Cushing's syndrome. Reviews in endocrine & metabolic disorders, 17(3), 283–286. https://doi.org/10.1007/s11154-016-9399-3

Sweetnich, J. (2023, March 28). Calcium 101: Testing, top foods, & supplements. Rupa Health. https://www.rupahealth.com/post/calcium-101-testing-top-foods-supplementsΒ 

Sweetnich, J. (2023, June 12). Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplements

Sweetnich J. Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. Published June 12, 2023. https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplementsΒ 

Thiel, A., Reis, A.-C., Haase, M., Goh, G., Schott, M., Willenberg, H. S., & Scholl, U. I. (2015). PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. European Journal of Endocrinology, 172(6), 677–685. https://doi.org/10.1530/eje-14-1113

Tomita A. (1998). Nihon rinsho. Japanese journal of clinical medicine, 56(6), 1574–1578.

Trabzonlu, L., Agirlar Trabzonlu, T., Gurbuz, Y., & Ceylan, S. (2020). ACTH-Cell Pituitary Adenoma With Signet Ring Cells: A Rare Case Report and Review of The Literature. Applied immunohistochemistry & molecular morphology : AIMM, 28(2), e13–e16. https://doi.org/10.1097/PAI.0000000000000639

Weinberg, J. ACTH Hormone: Roles, Regulation, and Health Implications. (2024, April 5). Rupa Health. https://www.rupahealth.com/post/acth-hormone-roles-regulation-and-health-implications

Whitworth, J. A., Williamson, P. M., Mangos, G., & Kelly, J. J. (2005). Cardiovascular consequences of cortisol excess. Vascular Health and Risk Management, 1(4), 291–299. https://doi.org/10.2147/vhrm.2005.1.4.291

Yoshimura, H. Top Labs To Run Bi-Annually On Your Irregular Menstrual Cycle Patients. (2023, August 7). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-irregular-menstrual-cycle-patients

Yoshimura, H. (2023, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview

Young, A. H. (2004). Cortisol in Mood Disorders. Stress, 7(4), 205–208. https://doi.org/10.1080/1025389050006918β€Œ

Zilio, M., Barbot, M., Ceccato, F., Camozzi, V., Bilora, F., Casonato, A., Frigo, A. C., Albiger, N., Daidone, V., Mazzai, L., Mantero, F., & Scaroni, C. (2014). Diagnosis and complications of Cushing's disease: gender-related differences. Clinical Endocrinology, 80(3), 403–410. https://doi.org/10.1111/cen.12299

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Adrenal
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.